3/28/20 Buprenorphine Waiver Eligibility Training for Clinical Providers: Nuvance Health

Saturday, March 28 2020, 8:00 AM - 1:00 PM [EST]

Register Now

1. Select Seats

2. Review and Proceed

This event is currently not on sale, please contact the event organizer for any additional questions.

REGISTRATION

Free Buprenorphine Waiver Training PARTIAL APPROVAL - Free

Registration closes on 03/28/2020

Enter your discount code

  • Fee
  • Total amount

Saturday, March 28 2020, 8:00 AM - 1:00 PM [EST]

                

 

 

The NYSDOH, AIDS Institute in partnership with Nuvance Health, is sponsoring a free Buprenorphine Waiver Eligibility Training for Clinical Providers. In response to opioid overdose deaths in New York State, increased access to buprenorphine treatment for opioid use disorder is urgently needed. Physicians, Nurse Practitioners, Physician Assistants, Medical Residents, Clinical Nurse Specialists, Certified Registered Nurse Anesthetists, and Certified Nurse Midwifes are welcome to attend.

 

Under current regulations, authorized practitioners (MDs, DOs, NPs, PAs, CNSs, CRNAs, and CNMs) are required to obtain a ‘waiver’ to prescribe buprenorphine. To acquire this waiver, physicians are required to complete a standardized buprenorphine waiver 8-hour training. Nurse Practitioners (NPs) and Physician Assistants (PAs), Clinical Nurse Specialists (CNS), Certified Registered Nurse Anesthetists (CRNA), and Certified Nurse Midwifes (CNM), are required to complete the standardized buprenorphine waiver 8-hour training as well as an additional 16 hours of online training as established by the Comprehensive Addiction and Recovery Act (CARA). Residents may also take the course and apply for their waiver once they receive their DEA license. The buprenorphine waiver 8-hour training is offered in a ‘half and-half’ format [4.5 hours of in-person training followed up by 3.5 hours of online training]. Upon completion of the required training, providers will meet the requirement of the DATA 2000 to apply for a waiver to prescribe buprenorphine for opioid-dependent patients. Please contact us for further information.

 

CME CREDITS: The University of Rochester School of Medicine and Dentistry designates this live activity for a maximum of 4.50 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. The University of Rochester School of Medicine and Dentistry is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

  

Trainer: Dr. Kelly Ramsey, MD, Hudson River Healthcare, Poughkeepsie, NY

                        

Location: Putnam Hospital, 670 Stoneleigh Avenue, Carmel NY 10512, Michael T. Weber Community Conference Room  

 

Directions: https://goo.gl/maps/XFeXFDjtXaU7Q1iG9 

Questions: Contact

Keith Prazeres, 845-278-5527 or cell 203-313-9089, keith.prazeres@nuvancehealth.org

 

ACCREDITATION: This activity has been planned and implemented by NYSDOH, AIDS Institute in accordance with the accreditation requirements and policies of the American Academy of Addiction Psychiatry (AAAP) and in partnership with Nuvance Health.

 

Funding for this course was made possible (in part) by grant no. 1H79TI081968 SAMHSA.  The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does it mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government. 

 

The Buprenorphine Waiver Training is supported in part by Overdose Data to Action, funded by the Centers for Disease Control and Prevention. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the Centers for Disease Control and Prevention or the Department of Health and Human Services

 

     

 

 

                                                                                                             

              

 

 

 

 

 

 

 

 

 

NYSDOH/Health Research Inc.